NEW YORK – Bio-Techne said Monday that it has formed a strategic European distribution partnership with Thermo Fisher Scientific.

纽约–Bio-Techne周一表示，它已与Thermo Fisher Scientific建立了战略性的欧洲分销合作伙伴关系。

Financial terms of the deal were not disclosed.

交易的财务条款未披露。

Under the agreement, Thermo Fischer will distribute Bio-Techne's portfolio of products through the European arm of its Fisher Scientific channel. Bio-Techne's portfolio of antibodies, proteins, immunoassay kits, reagents, and enzymes supporting cell and gene therapy, immunology, and neuroscience will be distributed to labs and research institutions..

根据协议，Thermo Fischer将通过其Fisher Scientific频道的欧洲分支分销Bio-Techne的产品组合。Bio-Techne的抗体、蛋白质、免疫测定试剂盒、试剂和支持细胞和基因治疗、免疫学和神经科学的酶组合将分发给实验室和研究机构。。

'By leveraging the Fisher Scientific channel's extensive European distribution network and industry expertise, we aim to enhance support for researchers and accelerate scientific discoveries that address some of the most pressing challenges in healthcare today,' Kim Kelderman, president and CEO of Bio-Techne, said in a statement..

Bio-Techne总裁兼首席执行官Kim Kelderman在一份声明中说：“通过利用Fisher Scientific channel广泛的欧洲分销网络和行业专业知识，我们旨在加强对研究人员的支持，加速科学发现，以应对当今医疗保健领域最紧迫的挑战。”。。

The agreement underscores Bio-Techne's interest in the European market. Last week, the Minneapolis-based company filed a patent infringement lawsuit in Europe against Molecular Instruments, one day after a UK court found the patents in question to be invalid.

该协议突显了Bio-Techne对欧洲市场的兴趣。上周，这家总部位于明尼阿波利斯的公司在欧洲针对Molecular Instruments提起了专利侵权诉讼，一天前，英国法院裁定这些专利无效。